May 1, 2014

MedCity News

Morgenthaler, ATV vets team up for new $172M early-stage life science venture capital fund

Four general partners from Advanced Technology Ventures‘ and Morgenthaler Ventures‘ life science teams have joined forces to invest up to $172 million in biopharmaceutical and medical device startups.

Lightstone Ventures, led by Michael Carusi and Jean George from ATV and Morgenthaler’s Chris Christoffersen and Hank Plain, said today it’s closed its first life science venture capital fund for early-stage companies.

Already the fund has three companies in its portfolio: Catabasis Pharmaceuticals, a clinical-stage company developing treatments for inflammatory and metabolic diseases; FIRE1, a stealthy spin-out of medical device incubator The Foundry; and EarLens, which is making an improved hearing device.

To read the full article, visit: